AnalystBook Research · Company Intelligence

Esquire Financial Holdings, Inc.

ESQNasdaq

Built from Esquire Financial Holdings, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Net income increased 16.4% to $50.8M, while Buybacks increased 0.0% to $286.0K.

The read at a glance✓ Audited against SEC data
  • EarningsFY2025 net income $50.8MOK
  • ProfitabilityNet income $50.8MOK
  • Balance-sheet lensCredit, capital, funding and liquidityOK
  • AccountingNo applicable forensic screenNote
  • Insiders0 buys; 7 sells in 365 daysNote
  • Capitaldividends paid were $5.9M; share repurchases were $286.0KNote

Business

Esquire Financial Holdings, Inc.: ("Esquire Financial" or the "Company") is a financial holding company headquartered in Jericho, New York and registered under the Bank Holding Company Act ("BHCA") of 1956, as amended (the "BHC Act").

Leadership changes

From Esquire Financial Holdings, Inc.'s own filings, the day they're filed.

  • Raymond Kelly · Directors · appointmenteff. 2025-06-06
  • Rena Nigam · Directors · appointmenteff. 2024-01-03
  • Selig Zises · director · departure

Latest filings

  • 10-Q · Quarterly report2026-08-10
  • 8-K · Company announcement2026-08-03
  • 8-K · Company announcement2026-07-30
  • 8-K · Company announcement2026-07-23
  • 8-K · Company announcement2026-06-24
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Esquire Financial Holdings, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.